Vernalis Plc - Price Analysis Snapshot

This Report features up to a ten-year record of the equity Price history for Vernalis Plc. Tabular results include the High, Low and Closing price for the quarter. There is also a calculation of percentage change in price for both Quarterly and Annual periods. Price values are adjusted for stock splits and dividends.

Vernalis Plc. The Group's principal activity is to develop and commercialize pharmaceutical products for a range of medical disorders. It has expertise both in de- novo structure and fragment-based drug discovery and pre-clinical and clinical development. The Group has seven product candidates in clinical development (two of which are partnered), two programmes in pre-clinical (one with a partner) and other competitive research programmes. The Group operates in the United Kingdom, Rest of Europe, North America and Rest of the World. On 01-Jul-2008, the Group completed the sale of Apokyn and Vernalis Pharmaceuticals Inc.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report